ANTENGENE ANNOUNCES XPOVIO® (SELINEXOR) APPROVED FOR ITS THIRD INDICATION IN SOUTH KOREA, BRINGING FRESH HOPE TO PATIENTS WITH MM IN THE COUNTRY

Reuters · 10/18 02:35

Please log in to view news